[1] |
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2018,392(10159): 1789-1858.
|
[2] |
GARTLEHNER G, THIEDA P, HANSEN R A, et al.Comparative risk for harms of second-generation antide pressants: A systematic review and meta-analysis[J]. Drug Safety, 2008, 31(10): 851-865.
|
[3] |
CONRAD P, ADAMS C. The effects of clinical aromatherapy for anxiety and depression in the high risk postpartum woman-A pilot study [J]. Complementary Therapies in Clinical Practice, 2012, 18(3): 164-168.
|
[4] |
B A L L E L , O W E N - B O O T H B , G R A Y A , e t a l . A r o -matherapy for dementia [J]. The Cochrane Database of Systematic Reviews, 2020, 8(8): CD003150.
|
[5] |
DE SOUSA D P, SIL V A R H N, SIL V A E, et al. Essential oils and their constituents: An alternative source for novel antidepressants [J]. Molecules, 2017, 22(8):1290.
|
[6] |
DE SOUSA D P, DE ALMEIDA SOARES HOCAYENP, ANDRADE L N, et al. A systematic review of theanxiolytic-like effects of essential oils in animal models[J]. Molecules, 2015, 20(10): 18620-18660.
|
[7] |
KONG Y Y, W ANG T, W ANG R, et al. Inhalation of Roman chamomile essential oil attenuates depressive-like behaviors in Wistar Kyoto rats [J]. Science China Life Sciences, 2017, 60(6): 647-655.
|
[8] |
FOGAC? A M V, WU M, LI C, et al. Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses [J]. Molecular Psychiatry, 2021, 26: 3277-3291.
|
[9] |
TREMBLAY R, LEE S, RUDY B. GABAergic in-terneurons in the neocortex: From cellular properties to circuits [J]. Neuron, 2016, 91(2): 260-292.
|
[10] |
FOGAC? A M V, DUMAN R S. Cortical GABAergicdys function in stress and depression: New insights for therapeutic interventions [J]. Frontiers in Cellular Neuroscience, 2019, 13: 87.
|
[11] |
BRADLEY B F, STARKEY N J, BROWN S L, et al.The effects of prolonged rose odor inhalation in two animal models of anxiety [J]. Physiology & Behavior,2007, 92(5): 931-938.
|
[12] |
KIM K S, HAN P L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters [J]. Journal of Neuroscience Research,2006, 83(3): 497-507.
|
[13] |
GRUNEBAUM M F, GALF AL VY H C, CHOO T H,et al. Ketamine for rapid reduction of suicidal thoughtsin major depression: A midazolam-controlled randomized clinical trial [J]. The American Journal of Psychiatry, 2018, 175(4): 327-335.
|
[14] |
CHU X, ZHOU Y, HU Z, et al. 24-hour-restraint stress induces long-term depressive-like phenotypes in mice[J]. Scientific Reports, 2016, 6: 32935.
|
[15] |
LIU L, XU H F, W ANG J, et al. Cell type-differential modulation of prefrontal cortical GABAergic interneurons on low gamma rhythm and social interaction [J].Science Advances, 2020, 6(30): eaay4073.
|
[16] |
WHISSELL P D, CAJANDING J D, FOGEL N, etal. Comparative density of CCK- and PV-GABA cellswithin the cortex and hippocampus [J]. Frontiers in Neuroanatomy, 2015, 9: 124.
|
[17] |
YANG Y, CUI Y, SANG K, et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve de-pression [J]. Nature, 2018, 554: 317-322
|
[18] |
ZIEMBA P M, SCHREINER B S P, FLEGEL C, et al.Activation and modulation of recombinantly express edserotonin receptor type 3A by terpenes and pungent substances [J]. Biochemical and Biophysical Research Communications, 2015, 467(4): 1090-1096.
|
[19] |
GUPTA D, RADHAKRISHNAN M, KURHE Y. On-dansetron, a 5HT3 receptor antagonist reverses de-pression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system [J]. European Journal of Pharmacology,2014, 744: 59-66.
|
[20] |
BHATNAGAR S, SUN L M, RABER J, et al. Changesin anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3Areceptor [J]. Physiology & Behavior, 2004, 81(4): 545-555.
|
[21] |
YOU I J, JUNG Y H, KIM M J, et al. Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficientmice are mediated by changes in expression of 5-HT1A,GABAA, and NMDA receptors [J]. Neuropharmacology, 2012, 62(2): 1034-1043.
|
[22] |
MANNA S S S, UMATHE S N. A possible participation of transient receptor potential vanilloid type 1channels in the antidepressant effect of fluoxetine [J].European Journal of Pharmacology, 2012, 685(1/2/3):81-90.
|
[23] |
OHKA W ARA S, TANAKA-KAGA W A T, FU-RUKA W A Y, et al. Activation of the human transient receptor potential vanilloid subtype 1 by essential oils[J]. Biological & Pharmaceutical Bulletin, 2010, 33(8):1434-1437.
|
[24] |
FILIPOVIC D, ZLATKOVIC J, GASS P, et al. The differential effects of acute vs. chronic stress and their combination on hippocampal parvalbumin and in-ducible heat shock protein 70 expression [J]. Neuro-science, 2013, 236: 47-54.
|
[25] |
MACKOWIAK M, LATUSZ J, GLOW ACKA U, et al.Adolescent social isolation affects parvalbumin expression in the medial prefrontal cortex in the MAM-E17model of schizophrenia [J]. Metabolic Brain Disease,2019, 34(1): 341-352.
|
[26] |
SPIJKER S, KOSKINEN M K, RIGA D N. Incubation of depression: ECM assembly and parval bumininterneurons after stress [J]. Neuroscience & Biobehavioral Reviews, 2020, 118: 65-79.
|
[27] |
XU H F, LIU L, TIAN Y Y, et al. A disinhibitory microcircuit mediates conditioned social fear in the pre-frontal cortex [J]. Neuron, 2019, 102(3): 668-682.e5.
|
[28] |
LIN L C, SIBILLE E. Somatostatin, neuronal vulnerability and behavioral emotionality [J]. Molecular Psychiatry 2015, 20: 377-387.
|
[29] |
SIBILLE E, MORRIS H M, KOTA R S, et al. GABA-related transcripts in the dorsolateral prefrontal cortexin mood disorders [J]. International Journal of Neuro psychopharmacology, 2011, 14(6): 721-734.
|